The estimated Net Worth of Douglas M Lankler is at least $20.1 Million dollars as of 23 February 2024. Mr. Lankler owns over 95,755 units of Pfizer stock worth over $6,849,087 and over the last 12 years he sold PFE stock worth over $13,280,250. In addition, he makes $0 as Executive Vice President and General Counsel at Pfizer.
Douglas has made over 30 trades of the Pfizer stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 95,755 units of PFE stock worth $2,617,942 on 23 February 2024.
The largest trade he's ever made was exercising 115,342 units of Pfizer stock on 23 February 2022 worth over $3,153,450. On average, Douglas trades about 16,553 units every 46 days since 2012. As of 23 February 2024 he still owns at least 230,920 units of Pfizer stock.
You can see the complete history of Mr. Lankler stock trades at the bottom of the page.
Douglas M. Lankler serves as Executive Vice President, General Counsel of the Company. Executive Vice President, Chief Compliance and Risk Officer. Executive Vice President, Chief Compliance Officer. Senior Vice President and Chief Compliance. Senior Vice President, Deputy General Counsel and Chief Compliance Officer.
Douglas Lankler is 54, he's been the Executive Vice President and General Counsel of Pfizer since 2014. There are 24 older and 5 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Douglas's mailing address filed with the SEC is 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK, NY, 10001-2192.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read, and James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: